Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions

Molecular mechanisms of diabetic kidney disease

(2014) Kimberly Reidy et al.   JOURNAL OF CLINICAL INVESTIGATION

Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes

(2012) D. K. Kim et al.   DIABETOLOGIA

Tempol Reduces Podocyte Apoptosis via PARP Signaling Pathway in Experimental Diabetes Mellitus

(2012) Elisa B.M.I. Peixoto et al.   NEPHRON EXPERIMENTAL NEPHROLOGY

The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy

(2011) Matem Tunçdemir et al.   ACTA HISTOCHEMICA

Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy

(2011) ANDREW ADVANI et al.   NEPHROLOGY

Apoptosis occurs differentially according to glomerular size in diabetic kidney disease

(2011) D.-S. Jung et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production

(2011) J. Toyonaga et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential

(2009) Hiroyuki Mori et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes

(2008) C. Ruster et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION